Development of early diagnosis system for lung cancer based on sensor array and artificial intelligence using exhaled VOCs.
Use as an on-site diagnostic lung cancer early screening device.
AISpiration is an ETRI-research institute startup where the Electronics and Telecommunications Research Institute (ETRI) is a Korean government-funded research institution in Korea. ETRI has invested exhaled breath-based E-nose technology for mobile healthcare and developed biomarkers-based healthcare devices. Seoul National University Bundang Hospital (SNUH) conducted clinical trials on lung cancer patients.
AISpiration stands on two giants shoulders and continue to innovate healthcare industry by introducing accurate and convenient healthcare products and services based on big data and AI deep learning technology.
Download corporate brochure .